Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Roger J. Pomerantz
|
| gptkbp:developedBy |
protein therapeutics
antimicrobial agents |
| gptkbp:focusesOn |
antibiotic-resistant infections
bacteriophage therapies lysins |
| gptkbp:founded |
2008
|
| gptkbp:headquartersLocation |
gptkb:Yonkers,_New_York,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
ContraFect
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
exebacase
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
CFRX
|
| gptkbp:website |
https://www.contrafect.com/
|
| gptkbp:bfsParent |
gptkb:Sol_Barer
gptkb:Sol_J._Barer |
| gptkbp:bfsLayer |
7
|